AlphaStocks

AZN vs VGNT

As of Sep 20, 2026, Astrazeneca (AZN) scores 5.0/10 on AlphaStocks' five-model composite; Versigent (VGNT) has no composite score. AZN trades 14% below its model fair value.

AZN

ASTRAZENECA PLC

5.0

Consider Buy

$166.29

VGNT

Versigent PLC

No data

$45.88

AZN vs VGNT: Which is the Better Investment?

This comparison is algorithmically generated and is not financial advice.

MetricAZNVGNT
Scores & Fundamentals
Composite Score5.0/10
RatingConsider BuyNo data
Price$166.29$45.88
P/E Ratio25.4
ROE21.9%8.0%
Market Cap$260B
Fair Value$192.63
Dividend Yield1.9%
Sector Rank#111 of 168#194 of 194
Model Verdicts
PiotroskiStrongLimited Data
BuffettStrongLimited Data
GrahamCautionLimited Data
LynchNeutralLimited Data
GreenblattNeutralLimited Data
View full AZNanalysis →View full VGNTanalysis →

Related comparisons

Compare any two stocks →

AZN vs VGNT: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) is in the Health Care sector; Versigent PLC (VGNT) is in Consumer Discretionary.

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer